BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12175102)

  • 1. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
    Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
    Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
    Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.
    de Larrañaga GF; Forastiero RR; Martinuzzo ME; Carreras LO; Tsariktsian G; Sturno MM; Alonso BS
    Lupus; 2000; 9(8):594-600. PubMed ID: 11035434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
    Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
    Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
    Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
    Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; de Larrañaga GF
    Lupus; 2005; 14(2):129-36. PubMed ID: 15751817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
    Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
    J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy.
    Ribeiro SLE; Pereira HLA; Boechat AL; Silva NP; Sato EI; das Graças Souza Cunha M; de Souza Passos LF; Dos-Santos MC
    Adv Rheumatol; 2019 Nov; 59(1):52. PubMed ID: 31779703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of F1 + 2/TAT ratios in Japanese patients with antiphospholipid syndrome].
    Naitoh S; Ieko M; Takeda M; Atsumi T; Koike T
    Rinsho Byori; 2000 Jun; 48(6):540-6. PubMed ID: 10897673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
    Arkel YS; Paidas MJ; Ku DH
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and platelets.
    De Jong A; Ziboh V; Robbins D
    Curr Rheumatol Rep; 2000 Jun; 2(3):238-45. PubMed ID: 11123065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Bédard E; Rodés-Cabau J; Houde C; Mackey A; Rivest D; Cloutier S; Noël M; Marrero A; Côté JM; Chetaille P; Delisle G; Leblanc MH; Bertrand OF
    Stroke; 2007 Jan; 38(1):100-4. PubMed ID: 17122434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.